AbbVie Inc. (ABBV)

CIK 0001551152 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-31) · 99.1  |  8-K (2026-07-06) · 99.1
Q1-2026 8-K (2026-04-29) · 99.1  |  8-K (2026-04-03) · 99.1
Latest FY-2025 8-K (2026-02-04) · 99.1  |  8-K (2026-01-07) · 99.1
Q3-2025 8-K (2025-10-31) · 99.1  |  8-K (2025-10-03) · 99.1
Q2-2025 8-K (2025-07-31) · 99.1  |  8-K (2025-07-03) · 99.1
Q1-2025 8-K (2025-04-25) · 99.1  |  8-K (2025-04-03) · 99.1
FY-2024 8-K (2025-01-31) · 99.1  |  8-K (2025-01-06) · 99.1
Q3-2024 8-K (2024-10-30) · 99.1  |  8-K (2024-10-03) · 99.1
Q2-2024 8-K (2024-07-25) · 99.1  |  8-K (2024-07-03) · 99.1
Q1-2024 8-K (2024-04-26) · 99.1  |  8-K (2024-04-03) · 99.1
FY-2023 8-K (2024-02-02) · 99.1  |  8-K (2024-01-05) · 99.1
Q3-2023 8-K (2023-10-27) · 99.1  |  8-K (2023-10-04) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Audit Information
—
Statements
Consolidated Statements of Earnings
Consolidated Statements of Comprehensive Income
Consolidated Statements of Comprehensive Income (P)
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Equity
Consolidated Statements of Equity (deficit)
Consolidated Statements of Cash Flows
Notes
Background
—
Background and Basis of Presentation
—
Basis of Presentation
—
Collaborations
Cybersecurity Risk Management and Strategy Disclosure
—
Debt, Credit Facilities and Commitments and Contingencies
—
Earnings Per Share
Equity
Financial Instruments and Fair Value Measures
Fourth Quarter Financial Results (unaudited)
—
Goodwill and Intangible Assets
Income Taxes
Insider Trading Arrangements
Integration and Restructuring Plans
Leases
—
Legal Proceedings and Contingencies
Licensing, Acquisitions and Other Arrangements
—
Licensing, Acquisitions, and Other Arrangements
—
Pay Vs Performance Disclosure
Post-employment Benefits
Restructuring Plans
Segment and Geographic Area Information
—
Segment Information
—
Summary of Significant Accounting Policies
—
Supplemental Financial Information